TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
Kassem L, Deygas M, Fattet L, Lopez J, Goulvent T, Lavergne E, Chabaud S, Carrabin N, Chopin N, Bachelot T, Gillet G, Treilleux I, Rimokh R.
Kassem L, et al. Among authors: carrabin n.
BMC Cancer. 2015 Jun 4;15:453. doi: 10.1186/s12885-015-1471-y.
BMC Cancer. 2015.
PMID: 26040677
Free PMC article.